Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series
Sandra Susanibar-Adaniya et al · Nature Publishing Group · 2026
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, S. S. A. E. (2026). Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series. https://doi.org/10.1038/s41408-026-01473-3
MLA
al, Sandra Susanibar-Adaniya et. "Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series." 2026. https://doi.org/10.1038/s41408-026-01473-3.
Chicago
al, Sandra Susanibar-Adaniya et. 2026. "Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series.". https://doi.org/10.1038/s41408-026-01473-3.
Harvard
al, S. S. A. E. 2026, Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series, Nature Publishing Group, available at: https://doi.org/10.1038/s41408-026-01473-3 [Accessed 1 Jul. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series
- Autor / colaboradores
- Sandra Susanibar-Adaniya et al
- Editorial
- Nature Publishing Group
- Año de publicación
- 2026
- ISSN
- 2044-5385
- ISSN
- 2044-5385
- Idioma
- eng